A L Kovalenko Selected Research

Immunologic Factors (Immunomodulators)

1/2017	[Clinical efficacy of the immunomodulatory agent cycloferon (tablets) in viral respiratory infections: Results of a systematic review and meta-analysis].
1/2011	[Immunomodulators in combined therapy of patients with chronic hepatitis].
1/2010	[Pathogenetically substantiated therapy of patients with virus hepatitis C, quality of life, and the disease outcome risk (clinical survey)].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A L Kovalenko Research Topics

Disease

9	Infections 01/2016 - 01/2000
8	Virus Diseases (Viral Diseases) 01/2017 - 11/2004
8	Tuberculosis (Tuberculoses) 01/2014 - 01/2008
7	Human Influenza (Influenza) 01/2014 - 09/2000
6	Neoplasms (Cancer) 12/2023 - 01/2000
6	Brain Ischemia (Cerebral Ischemia) 01/2023 - 04/2004
6	Poisoning 01/2018 - 07/2001
5	Ischemic Stroke 01/2023 - 01/2014
5	Diabetic Foot 01/2018 - 01/2014
5	Cholestasis 01/2016 - 01/2010
5	Chronic Hepatitis C 01/2013 - 01/2010
4	Disease Progression 01/2018 - 01/2015
4	Hypoxia (Hypoxemia) 01/2018 - 01/2015
3	Type 2 Diabetes Mellitus (MODY) 01/2023 - 01/2016
3	Stroke (Strokes) 01/2023 - 01/2015
3	Osteochondrosis (Osgood Schlatter Disease) 01/2021 - 01/2017
3	Pneumonia (Pneumonitis) 01/2018 - 01/2009
3	Myocardial Infarction 02/2016 - 01/2002
3	Inflammation (Inflammations) 01/2014 - 01/2000
3	Ischemia 01/2014 - 04/2004
3	Fever (Fevers) 01/2012 - 01/2009
3	Chronic Hepatitis (Chronic Active Hepatitis) 01/2011 - 01/2010
3	Chronic Hepatitis B 11/2010 - 01/2010
2	Cognitive Dysfunction 01/2023 - 01/2011
2	Liver Diseases (Liver Disease) 12/2021 - 11/2010
2	Wounds and Injuries (Trauma) 01/2017 - 01/2011
2	Polyneuropathies (Polyneuropathy) 01/2017 - 01/2014
2	Body Weight (Weight, Body) 02/2016 - 01/2016
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2016 - 01/2016
2	Hepatomegaly 01/2016 - 01/2012
2	Brain Infarction 01/2015 - 01/2014
2	Ulcer 01/2015 - 11/2001
2	Alcoholism (Alcohol Abuse) 01/2015 - 01/2010
2	Brucellosis (Malta Fever) 01/2014 - 01/2010
2	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2014 - 01/2013
2	Hepatitis 01/2014 - 01/2011
2	Laryngitis 01/2013 - 01/2013
1	Colorectal Neoplasms (Colorectal Cancer) 12/2023
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2023
1	Diabetic Neuropathies (Diabetic Neuropathy) 01/2023
1	Pathologic Constriction (Stenosis) 01/2023
1	Thrombosis (Thrombus) 01/2023
1	Intrahepatic Cholestasis 12/2021
1	Pruritus (Itching) 12/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021
1	Intraoperative Complications 01/2020
1	postintensive care syndrome 01/2020
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2017

Drug/Important Bio-Agent (IBA)

29	cytoflavinIBA 01/2023 - 02/2000
28	10-carboxymethyl-9-acridanoneIBA 01/2017 - 01/2000
17	RemaxolIBA 12/2021 - 01/2008
10	Succinic Acid (Succinate)IBA 01/2023 - 07/2001
10	InterferonsIBA 01/2013 - 01/2000
9	AntioxidantsIBA 01/2016 - 01/2011
7	ReamberinIBA 01/2018 - 01/2010
6	SolutionsIBA 12/2021 - 01/2008
6	TabletsIBA 01/2017 - 01/2009
5	Antiviral Agents (Antivirals)IBA 01/2012 - 01/2010
4	Ethanol (Ethyl Alcohol)IBA 01/2016 - 07/2001
4	Free RadicalsIBA 01/2015 - 07/2001
3	Immunologic Factors (Immunomodulators)IBA 01/2017 - 01/2010
3	Neuroprotective AgentsIBA 04/2005 - 11/2003
3	NeuronolIBA 09/2004 - 12/2003
2	Cytostatic AgentsIBA 12/2023 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2015
2	Arginine (L-Arginine)FDA Link 01/2023 - 01/2016
2	S-Adenosylmethionine (Ademetionine)IBA 12/2021 - 01/2011
2	BilirubinIBA 12/2021 - 09/2010
2	Urea (Carbamide)FDA LinkGeneric 01/2016 - 01/2015
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2015 - 01/2014
2	Meglumine FDA Link 01/2014 - 01/2011
2	EnzymesIBA 01/2014 - 01/2008
2	Ribavirin (Virazole)FDA LinkGeneric 01/2012 - 01/2012
2	AcidsIBA 01/2011 - 01/2002
2	Therapeutic UsesIBA 11/2010 - 01/2010
2	Saline SolutionIBA 09/2010 - 02/2000
1	Lysine (L-Lysine)FDA Link 12/2023
1	Histones (Histone)IBA 12/2023
1	Acetates (Acetic Acid Esters)FDA Link 12/2023
1	acridoneIBA 12/2023
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2023
1	NAD (NADH)IBA 01/2023
1	AnticoagulantsIBA 01/2023
1	SodiumIBA 01/2023
1	Long-Acting Insulin (Insulin, Long Acting)FDA Link 01/2023
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2023
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2023
1	Transaminases (Aminotransferases)IBA 12/2021
1	Phenobarbital (Luminal)FDA Link 01/2018
1	barbituric acid (barbiturate)IBA 01/2018

Therapy/Procedure

44	Therapeutics 12/2023 - 01/2000
5	Drug Therapy (Chemotherapy) 01/2014 - 01/2010
4	Ligation 01/2020 - 09/2010
2	Aftercare (After-Treatment) 01/2017 - 01/2016
2	Critical Care (Surgical Intensive Care) 01/2016 - 07/2001
2	Length of Stay 01/2016 - 01/2010
2	Injections 01/2014 - 01/2002
1	Overlapping Surgery 01/2021
1	Neurological Rehabilitation 01/2020